- Harvard founders with work experience at Google and Bridgewater Associates.
- Globally recognized investors and advisors with multi-billion-dollar exits, including former Dean of MIT Engineering and Harvard/MIT professors.
- Bringing AIs from all around the world to defeat COVID and get humanity back on track.
- The market for AI services is estimated to reach $5.5 trillion by 2027.
- If we achieve our vision, we believe GenesisAI has the potential to become one of the most valuable technologies of all time.
- A global AI network that just works.
Economics, Harvard University. Previous experience at Bridgewater Associates. Serial entrepreneur. Recognized by media outlets including the New York Post, Forbes, and Yahoo Finance.
Computer Science, Harvard University. Senior Software Engineer work experience at Google.
PhD in Applied Physics, MS in Computational Science and Engineering both from Harvard John A. Paulson School of Engineering and Applied Sciences. Published multiple scientific papers and raised over $1 million in research grants.
When we were developing Palatine Analytics (a startup selling AI-powered employee performance monitoring systems), we learned that AI development is hindered by two fundamental problems:
- AI development is expensive
- Independent AI developers can neither monetize nor share their code.
Today, there are only around 10,000 AI developers in the world. 99% of companies cannot afford to hire their own team of AI engineers to create in-house AIs, nor do they have enough technical capabilities to correctly determine from which open-source APIs to grab existing AI code.
Astoundingly, there is no way for AIs to exchange data, learn from each other, leverage their capabilities, and trade services— let alone judge the quality of AIs (there is no reputation system). AIs are operating in a closed environment.
GenesisAI is a Machine Learning protocol. On top of this protocol, we are building a marketplace for AI products and services - an Amazon for AI services. The marketplace, which includes a built-in reputation system, connects companies in need of AI services, data, and models with companies interested in monetizing their AI tech. Initially, GenesisAI is focused on asset management space and recently entered the healthcare sector.
Amidst the global pandemic, all of us need to do our part to combat COVID. We need a global coordinated effort.
After getting overwhelming demand, GenesisAI decided to enter the healthcare sector. We are bringing AIs from all around the world to help battle COVID and aid humanity.
GenesisAI team is gathering AIs to develop detection, testing, diagnostic and treatment.
The initial focus will be on:
- AI that identifies people who are at high risk of getting really sick if they were to become infected
- AI that predicts future outbreaks
- AI that simulates the impact of different government policies
We have a beta product and have agreements with over 20 AI supply-side firms who wish to place their product on our marketplace and 25 demand-side firms who wish to purchase products on our marketplace.
All in all, if you believe in supporting our mission, join us and help us enable anyone in the world to access AI.
- Large corporations will no longer be the only entities able to develop and utilize AI. We believe in making AI accessible: “for the people, by the people.”
- By linking AI services with each other and increasing the supply of AI services, GenesisAI provides a web platform that offers low-cost AI services. This makes AI technology more efficient and affordable for businesses.
- Our technology enables different AIs to communicate with each other, exchange data and trade services. Anyone can develop and purchase AI services.
Invest as little as $100 to help us further develop our promising technology. The time is now.
Founders – studied computer science and economics at Harvard, and long work experience in the AI industry and in companies like Google and Bridgewater.
Advisors – 2 multi-billion-dollar exits, former Dean of MIT Engineering, $310M exit, MIT AI/ML professor, 2 Harvard computer science professors, 2 Harvard Business School professors
Use of Proceeds
If the offering's maximum Reg CF allocation of $444,609 is raised:
|Use||Value||% of Proceeds|
|Sales and Marketing||$147,151||33.1%|
If the offering's maximum amount of $2,499,998 across Reg. CF and Reg. D is raised:
|Use||Value||% of Proceeds|
|Sales and Marketing||$827,417||33.1%|
This is a side-by-side offering of Common Stock, under registration exemptions 4(a)(6) and 506(c), in GenesisAI Corporation. Up to $444,608.71 may be raised under the 4(a)(6) exemption. Netcapital will determine which exemption applies to your investment and notify you before you complete your investment.
The amount raised under the two exemptions must total at least $10,000 by October 1, 2020 at 11:59pm ET. If the total doesn’t reach its target, then your money will be refunded. GenesisAI may issue additional securities to raise up to $2,499,998, the offering’s maximum.
If the side-by-side offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:
These financial statements have been audited by an independent Certified Public Accountant.
The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemptions 4(a)(6) and 506(c) of the Securities Act of 1933. Similar information is sometimes offered in a Private Placement Memorandum for 506(c) offerings.
Ask a Question
Proofread your comment before submitting: once it's posted, you can’t edit or delete it. For the fastest help with the web site, email firstname.lastname@example.org instead of commenting.
Understand the Risks
Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.
Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.
The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.